selected scholarly activity
-
books
-
chapters
- Synapsin II. 5264-5274. 2018
- Contribution of Organized Retailing to Agricultural Distribution System: Prospects and Challenges. 37-58. 2016
- Implications of New Supply Chains on the Indian Farm Economy: An Overview. 1-25. 2016
- Organised Retailing and Agri-Business Implications of New Supply Chains on the Indian Farm Economy Preface. IX-X. 2016
- Synapsin II. 1-11. 2016
- Cell-Free Protein Synthesis and Purification of the Dopamine D2 Receptor. Neuromethods. 43-63. 2015
- Age Diversity-Toward a Balanced Board. 75-85. 2013
- As Companies Go Global, Boards Must Follow. 45-61. 2013
- Blend of Diverse Personalities. 97-103. 2013
- Board Composition: Veteran or Novice. 63-73. 2013
- Building an Effective Board. 105-113. 2013
- Diversity and the Effective Corporate Board INTRODUCTION. XI-XI. 2013
- Diversity-Toward an Effective Board. 1-11. 2013
- Gender Diversity-India and Singapore. 37-43. 2013
- Skill Diversity. 87-95. 2013
- Women on Boards. 13-35. 2013
- Regulation of synapses II by dopaminergic mechanisms. 215-233. 2012
- Curcumin: Implications in the treatment of central nervous system disease. 1-38. 2012
- Catecholamine Regulated Protein (CRP40), A Splice Variant of Mortalin-2: Functional Role in CNS Disorders. 191-207. 2012
- Cholecytokinin (CCK) Receptors. 385-436. 1987
- Noradrenergic signal transfer as a target of antidepressant therapy. 3-17. 1983
- Up- and Down-regulation of Noradrenergic Receptor Systems in Brain: Molecular Mechanisms and Physiological Significance. 29-40. 1982
- G Proteins and Animal Models of Parkinson's Disease. Neuromethods. 139-162.
- Modulation of G Proteins in Rat Striatum by Neuroleptic Drugs and a Peptidomimetic Analog of Pro-Leu-Gly-NH<sub>2</sub>. Neuromethods. 119-138.
- Monoclonal Antibodies. Neuromethods. 169-196.
-
conferences
- SUMOylation of Periplakin is critical for efficient re-organization of Keratin filament network.. Molecular Biology of the Cell. 2018
- Diffuse panbronchiolitis is not restricted to east asia - A mini literature review. European Respiratory Journal. 2018
- Hydrophobically-modified poly(oligoethylene glycol methacrylate)-based nanogels for the delivery of anti-psychotic drugs to the brain. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY. 2018
- Understanding the Structural Basis of Recognition between Plasmodium Falciparum and Human Sumoylation Machinery. Biophysical Journal. 220A-220A. 2018
- Abridged Methodology Development for Analyzing Transformer Winding During Lightning Surges. 2018 IEEE 8TH POWER INDIA INTERNATIONAL CONFERENCE (PIICON). 2018
- Estimation and Methods of Equalizing Leakage Reactance for Multi-Winding Transformers. 2018 20TH NATIONAL POWER SYSTEMS CONFERENCE (NPSC). 2018
- A Novel Design to Prevent Electricity Theft from Pole Mounted Distribution Boxes. 2016 NATIONAL POWER SYSTEMS CONFERENCE (NPSC). 2016
- Comprehensive modeling of Dry type foil winding transformer to analyse inter turn insulation under Lightning Impulse Voltage. 2016 NATIONAL POWER SYSTEMS CONFERENCE (NPSC). 2016
- Planar Electromagnetic Current Sensor for Distribution Transformer Application. 2016 NATIONAL POWER SYSTEMS CONFERENCE (NPSC). 2016
- Cerebral dopamine neurotrophic factor (CDNF) levels are increased in bipolar disorder. Bipolar Disorders. 100-100. 2015
- Evaluation of Anti-Nociceptive Properties of Novel Rho Kinase Inhibitors Using Animal Models of Neuropathic Pain. Indian Journal of Pharmacology. S247-S247. 2013
- Novel Semicarbazone Derivatives Effective Against DPN. Indian Journal of Pharmacology. S230-S230. 2013
- P3.421 Contributions of Intensive HIV Prevention Programme in Increasing HIV Testing Among Men Who Have Sex with Men in India: A Decomposition Analysis. Sexually Transmitted Infections. A280.2-A280. 2013
- Leakage Power Reduction for Domino Circuits in 45nm CMOS Technologies. 2012 2ND INTERNATIONAL CONFERENCE ON POWER, CONTROL AND EMBEDDED SYSTEMS (ICPCES 2012). 2012
- Design of negative allosteric modulators of the dopamine D-2 receptor. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY. 2011
- Curcumin Prevents the Development of Vacuous Chewing Movements in a Preclinical Animal Model of Human Tardive Dyskinesia and Proteomic Array Reveals a Possible Role of Target Proteins in the Mechanism of Action. Neurology. A90-A90. 2010
- Development and Evaluation of Allosteric Modulators of Dopamine D2 Receptors in Pre-Clinical Rat Models: Implications for the Treatment of Parkinson's Disease and Drug Induced Dyskinesia. Neurology. A82-A83. 2010
- Synthesis and Evaluation of Novel Compounds for the Treatment of Parkinson's Disease. Neurology. A319-A319. 2010
- Catecholamine regulated protein ( CRP40), as a possible clinical blood biomarker in schizophrenia. Schizophrenia Bulletin. 205-205. 2007
- Catecholamine regulated protein (CRP40), as a possible therapeutic agent in schizophrenia. Schizophrenia Bulletin. 472-472. 2007
- Increased gene expression and plasma levels of glucose dependent insulinotropic polypeptide following clozapine treatment. Journal of Psychopharmacology. A39-A39. 2005
- Design of melanocortin receptor agonists by conformational restriction approach. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY. U2658-U2659. 2005
- Role of free radicals in drug-induced tardivee dyskinesia. Journal of Psychopharmacology. A61-A61. 2004
- Glucose-dependent insulinotropic polypeptide (GIP) and its receptors: Gene expression in discrete human brain regions. The FASEB Journal. A993-A993. 2004
- Cloning of a human catecholamine regulated protein. The FASEB Journal. A238-A238. 2004
- Modulation of agonist binding to human dopamine receptor subtypes by L-proly-L-leucyl-glycinamide and a peptidomimetic analog. The FASEB Journal. A588-A588. 2004
- Selective modulation of dopamine D2L, and D-4 receptors by analogues of endogenous brain pepetide Pro-Leu-Glycinamide(2). The FASEB Journal. A587-A587. 2004
- Comparison of oral and depot risperidone on c-fos expression and its effects on serotonin and dopamine-like receptors in schizophrenic patients. Journal of Psychopharmacology. A47-A47. 2003
- Effect of risperidone and olanzapine on c-fos expression and 5-HT2A receptors in schizophrenic patients. Journal of Psychopharmacology. A47-A47. 2003
- Risperidone modulates the expression of a diverse set of human genes in human neuronal SH-SY5Y cells. Journal of Psychopharmacology. A47-A47. 2003
- Expression of a 40-kda catecholamine-regulated protein in the inner retina. Investigative Ophthalmology and Visual Science. U162-U162. 2002
- NMDA receptor-mediated modulation of dopamine neurotransmission in the central nervous system.. The FASEB Journal. 929-929. 1996
- BRAIN SPECIFIC NOVEL CATECHOLAMINE ABSORBING PROTEINS - DEVELOPMENTAL AND PHARMACOLOGICAL STUDIES. The FASEB Journal. A1860-A1860. 1992
- Modulation of high-affinity CNS dopamine D2 receptor by l-pro-l-leu-glycinamide (PLG) analogue. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 821-827. 1990
- MODULATION OF CNS DOPAMINE D2 RECEPTOR BY L-PROLYL-L-LEUCYL-GLYCINAMIDE (PLG) AND ITS ANALOGS. The FASEB Journal. A1400-A1400. 1988
- PURIFICATION OF THE D1 DOPAMINE RECEPTOR USING AFFINITY-CHROMATOGRAPHY. The FASEB Journal. A1397-A1397. 1988
- RECOVERY OF PLATINUM GROUP-METALS FROM AUTOMOBILE CATALYTIC-CONVERTERS - A REVIEW. PRECIOUS METALS 89. 483-501. 1988
- CHARACTERIZATION OF CHOLATE-SOLUBILIZED DOPAMINE D2 RECEPTORS COUPLED TO GUANINE-NUCLEOTIDE REGULATORY PROTEIN IN BOVINE STRIATUM. The FASEB Journal. 885-885. 1986
- PHOTOAFFINITY-LABELING OF HIGH-AFFINITY DOPAMINE BINDING-PROTEINS. The FASEB Journal. 564-564. 1986
- PURIFICATION OF DOPAMINE (D2) RECEPTOR BY AFFINITY-CHROMATOGRAPHY. The FASEB Journal. 1325-1325. 1982
- DIRECT EVIDENCE FOR L-PROLYL-LEUCYL-GLYCINAMIDE (PLG) RECEPTOR IN MAMMALIAN BRAIN. The FASEB Journal. 387-387. 1980
- LOCALIZATION AND CHARACTERIZATION OF MELATONIN RECEPTORS IN CNS CYTOSOL. The FASEB Journal. 1008-1008. 1980
- RAPID METHOD FOR MEASURING H-3-SPIROPERIDOL BINDING TO SOLUBILIZED RECEPTORS FROM BOVINE STRIATUM. The FASEB Journal. 1008-1008. 1980
- SOLUBILIZED NEUROLEPTIC RECEPTOR AND DOPAMINE-STIMULATED ADENYLATE-CYCLASE. The FASEB Journal. 528-528. 1980
- EFFECT OF NISOXETINE AND FLUOXETINE ON THE SENSITIVITY OF THE NOREPINEPHRINE (NE) RECEPTOR COUPLED ADENYLATE-CYCLASE SYSTEM IN RAT-BRAIN CORTEX. PHARMACOLOGIST. 248-248. 1979
- DESENSITIZATION OF NOREPINEPHRINE (NE) RECEPTOR COUPLED ADENYLATE-CYCLASE SYSTEM FOLLOWING ANTIDEPRESSANTS WHICH INHIBIT SEROTONIN (5HT) REUPTAKE. PHARMACOLOGIST. 230-230. 1978
- EFFECT OF SUBSTANTIA NIGRA LESION ON DOPAMINE-STIMULATED ADENYLATE-CYCLASE AND DOPAMINE-RECEPTOR BINDING IN CAUDATE-NUCLEUS. The FASEB Journal. 390-390. 1978
- PRESYNAPTIC AND POSTSYNAPTIC EFFECTS OF SULPIRIDE AND OTHER SUBSTITUTED BENZAMIDES. The FASEB Journal. 319-319. 1977
- CATALYTIC AND RECEPTOR COMPONENTS OF ENHANCED DOPAMINE-STIMULATED ADENYLATE-CYCLASE IN 2 BEHAVIORALLY DISTINCT STRIATAL DENERVATION SYNDROMES. The FASEB Journal. 456-456. 1976
- CNS TRANSMITTERS AND HYPOTHALAMUS. The FASEB Journal. 544-544. 1976
- EFFECT OF A HYPOTHALAMIC FACTOR ON AMPHETAMINE TOXICITY AND BRAIN CATECHOLAMINES. PHARMACOLOGIST. 209-209. 1976
- EFFECTS OF MORPHINE ON DOPAMINE-STIMULATED ADENYLATE-CYCLASE AND ON CYCLIC-GMP FORMATION IN MONKEY BRAIN AMYGDALA. The FASEB Journal. 428-428. 1976
-
journal articles
- In situ-gelling hydrophobized starch nanoparticle-based nanoparticle network hydrogels for the effective delivery of intranasal olanzapine to treat brain disorders. International Journal of Biological Macromolecules. 277:134385-134385. 2024
- Cannabidiol Protects Striatal Neurons by Attenuating Endoplasmic Reticulum Stress. Cannabis and Cannabinoid Research. 8:299-308. 2023
- Diffuse Panbronchiolitis Cases in India: An Update. Indian Journal of Respiratory Care. 7:113-114. 2022
- Decreased Expression of Cerebral Dopamine Neurotrophic Factor in Platelets of Probable Alzheimer Patients. Alzheimer Disease and Associated Disorders. 36:269-271. 2022
- Investigation of blood-brain barrier disruption in an animal model of mania induced by D-amphetamine. Journal of Affective Disorders Reports. 9:100368-100368. 2022
- Ketamine-induced neurotoxicity is mediated through endoplasmic reticulum stress in vitro in STHdhQ7/Q7 cells. NeuroToxicology. 91:321-328. 2022
- Using the Intranasal Route to Administer Drugs to Treat Neurological and Psychiatric Illnesses: Rationale, Successes, and Future Needs. CNS Drugs. 36:739-770. 2022
- Effect of Chronic Treatment with D2 Allosteric Modulator PAOPA on the Expression of Cerebral Dopamine Neurotrophic Factor (CDNF) in Select Brain Regions. International Journal of Peptide Research and Therapeutics. 27:2551-2557. 2021
- Investigation of Blood-Brain Barrier Disruption in an Animal Model of Mania Induced by d-Amphetamine 2021
- The Effect of PAOPA, a Novel Allosteric Modulator of Dopamine D2 Receptors, on Signaling Proteins Following Sub-Chronic Administration in Rats. Current molecular pharmacology. 14:469-476. 2021
- C. elegans electrotaxis behavior is modulated by heat shock response and unfolded protein response signaling pathways. Scientific Reports. 11:3115. 2021
- In situ-gelling starch nanoparticle (SNP)/O-carboxymethyl chitosan (CMCh) nanoparticle network hydrogels for the intranasal delivery of an antipsychotic peptide. Journal of Controlled Release. 330:738-752. 2021
- Novel mechanism of action for the mood stabilizer lithium. Bipolar Disorders. 23:76-83. 2021
- Therapeutic effects of TP5, a Cdk5/p25 inhibitor, in in vitro and in vivo models of Parkinson’s disease. Curr Res Neurobiol. 2:100006-100006. 2021
- Drosophila ELYS regulates Dorsal dynamics during development. Journal of Biological Chemistry. 295:2421-2437. 2020
- Decreased Expression of Cerebral Dopamine Neurotrophic Factor in Platelets of Stroke Patients. Journal of Stroke and Cerebrovascular Diseases. 29:104502-104502. 2020
- Study on manufacturer–dealer relationships for strategic alignment. Journal of Global Operations and Strategic Sourcing. 13:70-87. 2019
- Single-site glycine-specific labeling of proteins. Nature Communications. 10:2539. 2019
- Financial integration and macroeconomic volatility: evidence from Asia. Journal of Economic and Administrative Sciences. 35:94-112. 2019
- Reduced expression of synapsin II in a chronic phencyclidine preclinical rat model of schizophrenia. Synapse. 73:e22084. 2019
- SUMOylation of periplakin is critical for efficient reorganization of keratin filament network. Molecular Biology of the Cell. 30:357-369. 2019
- Single-Site Labeling of Native Proteins Enabled by a Chemoselective and Site-Selective Chemical Technology. Journal of the American Chemical Society. 140:15114-15123. 2018
- An Endogenous Reactive Oxygen Species (ROS)‐Activated Histone Deacetylase Inhibitor Prodrug for Cancer Chemotherapy. ChemMedChem. 13:2073-2079. 2018
- Diffuse panbronchiolitis research in MEDLINE (1969–2017): Report of a bibliometric analysis. Respiratory Investigation. 56:312-319. 2018
- Stabilization of Soil under Foundation and Pavements Using Fly Ash. Ambient Science. 5. 2018
- Differential Expression of Synapsin I and II upon Treatment by Lithium and Valproic Acid in Various Brain Regions. International Journal of Neuropsychopharmacology. 21:616-622. 2018
- C. elegans MANF Homolog Is Necessary for the Protection of Dopaminergic Neurons and ER Unfolded Protein Response. Frontiers in Neuroscience. 12:544. 2018
- The Dopamine Allosteric Agent, PAOPA, Demonstrates Therapeutic Potential in the Phencyclidine NMDA Pre-clinical Rat Model of Schizophrenia. Frontiers in Behavioral Neuroscience. 12:302. 2018
- Intranasal delivery of antipsychotic drugs. Schizophrenia Research. 184:2-13. 2017
- Backbone and side-chain resonance assignments of Plasmodium falciparum SUMO. Biomolecular NMR Assignments. 11:17-20. 2017
- Modelling and estimation of HIV prevalence and number of people living with HIV in India, 2010–2011. International Journal of STD and AIDS. 27:1257-1266. 2016
- Early age shrinkage pattern of concrete on replacement of fine aggregate with industrial by-product. JOURNAL OF RADIATION RESEARCH AND APPLIED SCIENCES. 9:386-391. 2016
- Improvements and important considerations for the 5-choice serial reaction time task—An effective measurement of visual attention in rats. Journal of Neuroscience Methods. 270:17-29. 2016
- Soil ecophysiological and microbiological indices of soil health: a study of coal mining site in Sonbhadra, Uttar Pradesh. Journal of Soil Science and Plant Nutrition. 16:778-800. 2016
- Cell Permeating Nano-Complexes of Amphiphilic Polyelectrolytes Enhance Solubility, Stability, and Anti-Cancer Efficacy of Curcumin. Biomacromolecules. 17:2375-2383. 2016
- A Novel Intranasal Spray Device for the Administration of Nanoparticles to Rodents. Journal of Medical Devices, Transactions of the ASME. 9. 2015
- Brain Targeting of a Water Insoluble Antipsychotic Drug Haloperidol via the Intranasal Route Using PAMAM Dendrimer. Molecular Pharmaceutics. 12:3380-3388. 2015
- Design, synthesis and biological evaluation of di-substituted noscapine analogs as potent and microtubule-targeted anticancer agents. Bioorganic and Medicinal Chemistry Letters. 25:2133-2140. 2015
- Change in expression of vesicular protein synapsin II by chronic treatment with D2 allosteric modulator PAOPA. Regulatory Peptides. 66:58-62. 2015
- Cell-free protein synthesis and purification of the Dopamine D2 receptor. Neuromethods. 96:43-63. 2015
- Role of presynaptic phosphoprotein synapsin II in schizophrenia. WORLD JOURNAL OF PSYCHIATRY. 5:260-260. 2015
- Correction: The CpG Island Encompassing the Promoter and First Exon of Human DNMT3LGene Is a PcG/TrX Response Element (PRE). PLoS ONE. 9:e105714-e105714. 2014
- Haloperidol-loaded intranasally administered lectin functionalized poly(ethylene glycol)–block-poly(d,l)-lactic-co-glycolic acid (PEG–PLGA) nanoparticles for the treatment of schizophrenia. European journal of pharmaceutics and biopharmaceutics. 87:30-39. 2014
- Effects of MK-801 treatment across several pre-clinical analyses including a novel assessment of brain metabolic function utilizing PET and CT fused imaging in live rats. Neuropharmacology. 77:325-333. 2014
- Synapsin II gene expression in the dorsolateral prefrontal cortex of brain specimens from patients with schizophrenia and bipolar disorder: effect of lifetime intake of antipsychotic drugs. Pharmacogenomics Journal. 14:63-69. 2014
- Design and Experimental Validation of a Radial Air Turbine Wheel of an Air Starter for Fighter Aircraft Application. ASME 2013 Gas Turbine India Conference. V001T05A001-V001T05A001. 2013
- Dysregulation of novel catecholamine‐regulated protein 40 (CRP40) in Parkinson's disease patients. Movement Disorders. 28:1460-1461. 2013
- Cell‐free protein synthesis and purification of human dopamine D2 receptor long isoform. Biotechnology Progress. 29:601-608. 2013
- A microfluidic phenotype analysis system reveals function of sensory and dopaminergic neuron signaling inC. eleganselectrotactic swimming behavior. Worm. 2:e24558-e24558. 2013
- Preclinical pharmacokinetic and toxicological evaluation of MIF-1 peptidomimetic, PAOPA: Examining the pharmacology of a selective dopamine D2 receptor allosteric modulator for the treatment of schizophrenia. Regulatory Peptides. 42:89-96. 2013
- PAOPA, a potent dopamine D2 receptor allosteric modulator, prevents and reverses behavioral and biochemical abnormalities in an amphetamine-sensitized preclinical animal model of schizophrenia. European Neuropsychopharmacology. 23:253-262. 2013
- Development of peptidomimetic ligands of Pro-Leu-Gly-NH2 as allosteric modulators of the dopamine D2 receptor. Beilstein Journal of Organic Chemistry. 9:204-214. 2013
- Effects of the Dopamine D2 Allosteric Modulator, PAOPA, on the Expression of GRK2, Arrestin-3, ERK1/2, and on Receptor Internalization. PLoS ONE. 8:e70736-e70736. 2013
- Human blood analysis reveals differences in gene expression of catecholamine-regulated protein 40 (CRP40) in schizophrenia. Schizophrenia Research. 143:203-206. 2013
- Behavioral effects of non-viral mediated RNA interference of synapsin II in the medial prefrontal cortex of the rat. Schizophrenia Research. 137:32-38. 2012
- Transformation of Pro-Leu-Gly-NH2 Peptidomimetic Positive Allosteric Modulators of the Dopamine D2 Receptor into Negative Modulators. ACS Chemical Neuroscience. 3:274-284. 2012
- The implications of oxidative stress in tardive dyskinesia. Current Topics in Pharmacology. 15:43-56. 2011
- Alpha-phenyl-N-tert-butylnitrone prevents oxidative stress in a haloperidol-induced animal model of tardive dyskinesia: Investigating the behavioural and biochemical changes. Brain Research. 1412:28-36. 2011
- Curcumin prevents haloperidol‐induced development of abnormal oro‐facial movements: Possible implications of Bcl‐XL in its mechanism of action. Synapse. 65:788-794. 2011
- Medial prefrontal cortical synapsin II knock-down induces behavioral abnormalities in the rat: Examining synapsin II in the pathophysiology of schizophrenia. Schizophrenia Research. 130:250-259. 2011
- PAOPA, a potent analogue of Pro-Leu-glycinamide and allosteric modulator of the dopamine D2 receptor, prevents NMDA receptor antagonist (MK-801)-induced deficits in social interaction in the rat: Implications for the treatment of negative symptoms in schizophrenia. Schizophrenia Research. 125:88-92. 2011
- Specific binding of photoaffinity-labeling peptidomimetics of Pro-Leu-Gly-NH2 to the dopamine D2L receptor: Evidence for the allosteric modulation of the dopamine receptor. European Journal of Pharmacology. 641:96-101. 2010
- Atypical antipsychotic drugs upregulate synapsin II in the prefrontal cortex of post-mortem samples obtained from patients with schizophrenia. Schizophrenia Research. 120:229-231. 2010
- Antipsychotic drug use is correlated with CRP40/mortalin mRNA expression in the dorsolateral prefrontal cortex of human postmortem brain specimens. Schizophrenia Research. 119:228-231. 2010
- Role of AP-2α Transcription Factor in the Regulation of Synapsin II Gene Expression by Dopamine D1 and D2 Receptors. Journal of Molecular Neuroscience. 41:267-277. 2010
- Calreticulin transacetylase catalyzed modification of the TNF-α mediated pathway in the human peripheral blood mononuclear cells by polyphenolic acetates. Chemico-Biological Interactions. 185:263-270. 2010
- The Nup107-160 complex and γ-TuRC regulate microtubule polymerization at kinetochores. Nature Cell Biology. 12:164-169. 2010
- Cloning, characterization, and functional studies of a human 40-kDa catecholamine-regulated protein: implications in central nervous system disorders. Cell Stress and Chaperones. 14:555-567. 2009
- Vesicular stomatitis virus inhibits mitotic progression and triggers cell death. EMBO Reports. 10:1154-1160. 2009
- Behavioral abnormalities in synapsin II knockout mice implicate a causal factor in schizophrenia. Synapse. 63:662-672. 2009
- Allosteric Modulation of the Dopamine D2 Receptor by Pro-Leu-Gly-NH2 Peptidomimetics Constrained in Either a Polyproline II Helix or a Type II β-Turn Conformation. Journal of Medicinal Chemistry. 52:2043-2051. 2009
- X-Band High Power SSPA for Satellite On-Board Applications. Journal of Spacecraft Technology. 19:51-59. 2009
- Allosteric Modulation of the Dopamine Receptor by Conformationally Constrained Type VI β-Turn Peptidomimetics of Pro-Leu-Gly-NH2. Journal of Medicinal Chemistry. 50:6725-6729. 2007
- Synapsin II knockout mice show sensorimotor gating and behavioural abnormalities similar to those in the phencyclidine-induced preclinical animal model of schizophrenia. Schizophrenia Research. 97:292-293. 2007
- Differential modulation of a 40 kDa catecholamine regulated protein in the core and shell subcompartments of the nucleus accumbens following chronic quinpirole and haloperidol administration in the rat. Synapse. 61:835-842. 2007
- MIF-1 and its peptidomimetic analogs attenuate haloperidol-induced vacuous chewing movements and modulate apomorphine-induced rotational behavior in 6-hydroxydopamine-lesioned rats. Regulatory Peptides. 28:2009-2015. 2007
- Residue-level NMR View of the Urea-driven Equilibrium Folding Transition of SUMO-1 (1-97): Native Preferences Do Not Increase Monotonously. Journal of Molecular Biology. 361:180-194. 2006
- Translocation of AIF in the human and rat striatum following protracted haloperidol, but not clozapine treatment. Apoptosis : an international journal on programmed cell death. 11:663-672. 2006
- Local Structural Preferences and Dynamics Restrictions in the Urea-Denatured State of SUMO-1: NMR Characterization. Biophysical Journal. 90:2498-2509. 2006
- cDNA array reveals increased expression of glucose-dependent insulinotropic polypeptide following chronic clozapine treatment: role in atypical antipsychotic drug-induced adverse metabolic effects. Pharmacogenomics Journal. 6:131-140. 2006
-
Design and Synthesis of Photoaffinity-Labeling Ligands of the
l -Prolyl-l -leucylglycinamide Binding Site Involved in the Allosteric Modulation of the Dopamine Receptor. Journal of Medicinal Chemistry. 49:307-317. 2006 - Dopamine-D1 and -D2 receptors differentially regulate synapsin II expression in the rat brain. Neuroscience. 138:587-599. 2006
- Modulation of Agonist Binding to Human Dopamine Receptor Subtypes by l-Prolyl-l-leucyl-glycinamide and a Peptidomimetic Analog. Journal of Pharmacology and Experimental Therapeutics. 315:1228-1236. 2005
- Decreased expression of a 40-kDa catecholamine-regulated protein in the ventral striatum of schizophrenic brain specimens from the Stanley Foundation Neuropathology Consortium. Schizophrenia Research. 74:111-119. 2005
- Folding Regulates Autoprocessing of HIV-1 Protease Precursor. Journal of Biological Chemistry. 280:11369-11378. 2005
- Differential display polymerase chain reaction reveals increased expression of striatal rat glia-derived nexin following chronic clozapine treatment. Pharmacogenomics Journal. 4:379-387. 2004
- Electron spin resonance spectroscopy reveals alpha‐phenyl‐N‐tert‐butylnitrone spin‐traps free radicals in rat striatum and prevents haloperidol‐induced vacuous chewing movements in the rat model of human tardive dyskinesia. Synapse. 54:156-163. 2004
- Dynamin Interacts with Members of the Sumoylation Machinery. Journal of Biological Chemistry. 279:31445-31454. 2004
- Asymmetric modulation of a catecholamine‐regulated protein in the rat brain, following quinpirole administration. Synapse. 49:261-269. 2003
- iso-Lactam and reduced amide analogues of the peptidomimetic dopamine receptor modulator 3(R)-[(2(S)-Pyrrolidinylcarbonyl)amino]-2-oxo-1-pyrrolidineacetamide. Bioorganic and Medicinal Chemistry. 11:4103-4112. 2003
- Pro-Leu-glycinamide and its peptidomimetic, PAOPA, attenuate haloperidol induced vacuous chewing movements in rat: A model of human tardive dyskinesia. Regulatory Peptides. 24:313-319. 2003
-
Synthesis and Dopamine Receptor Modulating Activity of 3-Substituted γ-Lactam Peptidomimetics of
l -Prolyl-l -leucyl-glycinamide. Journal of Medicinal Chemistry. 46:727-733. 2003 - Cocaine treatment increases expression of a 40 kDa catecholamine‐regulated protein in discrete brain regions. Synapse. 47:33-44. 2003
- Effect of loxapine on peripheral dopamine-like and serotonin receptors in patients with schizophrenia.. Journal of Psychiatry & Neuroscience. 28:39-47. 2003
- Nicotinic Induction of Preproenkephalin and Tyrosine Hydroxylase Gene Expression in Butyrate-Differentiated Rat PC12 Cells: A Model for Adaptation to Gut-Derived Environmental Signals. Pediatric Research. 53:113-118. 2003
- PLG regulates hnRNP-L expression in the rat striatum and pre-frontal cortex: identification by ddPCR. Regulatory Peptides. 24:137-146. 2003
- Modulation of a 40-kDa catecholamine-regulated protein following d-amphetamine treatment in discrete brain regions. European Journal of Pharmacology. 453:13-19. 2002
- cDNA array reveals differential gene expression following chronic neuroleptic administration: implications of synapsin II in haloperidol treatment. Journal of Neurochemistry. 82:1533-1539. 2002
- Expression of the 40 kDa catecholamine regulated protein in the normal and injured rat retina. Journal of Chemical Neuroanatomy. 24:41-48. 2002
- Differential regulation of striatal G protein levels following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration in C57 BL/6 mice. Neuroscience Letters. 306:21-24. 2001
- Inverse agonist binding of peripheral benzodiazepine receptors in anxiety disorder. European Archives of Psychiatry and Clinical Neuroscience. 251:136-140. 2001
- Immunohistochemical localization of a 40-kDa catecholamine regulated protein in the nigrostriatal pathway. Brain Research. 900:314-319. 2001
- Modulation of a 40-kDa catecholamine regulated protein by dopamine receptor antagonists. European Journal of Pharmacology. 413:73-79. 2001
- Molecular cloning, localization and characterization of a 40‐kDa catecholamine‐regulated protein. Journal of Neurochemistry. 76:1142-1152. 2001
- l-Prolyl-l-leucyl-glycinamide and its peptidomimetic analog 3(R)-[(2(S)-pyrrolidylcarbonyl)amino]-2-oxo-1-pyrrolidineacetamide (PAOPA) attenuate haloperidol-induced c-fos expression in the striatum☆. Regulatory Peptides. 21:301-308. 2000
- Modulatory effects of PLG and its peptidomimetics on haloperidol-induced catalepsy in rats. Regulatory Peptides. 20:761-767. 1999
- Synthesis and dopamine receptor modulating activity of unsubstituted and substituted triproline analogues of l-prolyl-l-leucyl-glycinamide (PLG). Bioorganic and Medicinal Chemistry Letters. 9:2349-2352. 1999
- Modulation of agonist stimulated adenylyl cyclase and GTPase activity by l-pro-l-leu-glycinamide and its peptidomimetic analogue in rat striatal membranes. Neuroscience Letters. 269:21-24. 1999
-
Synthesis and Dopamine Receptor Modulating Activity of Substituted Bicyclic Thiazolidine Lactam Peptidomimetics of
l -Prolyl-l -leucyl-glycinamide. Journal of Medicinal Chemistry. 42:2977-2987. 1999 -
Synthesis and Dopamine Receptor Modulating Activity of Novel Peptidomimetics of
l -Prolyl-l -leucyl-glycinamide Featuring α,α-Disubstituted Amino Acids. Journal of Medicinal Chemistry. 42:1441-1447. 1999 -
Design, Synthesis, and Dopamine Receptor Modulating Activity of Spiro Bicyclic Peptidomimetics of
l -Prolyl-l -leucyl-glycinamide. Journal of Medicinal Chemistry. 42:628-637. 1999 - Modulation of Dopamine D<sub>2</sub> Receptor Expression by an NMDA Receptor Antagonist in Rat Brain. Journal of Molecular Neuroscience. 11:121-126. 1998
- Protection Against MPTP Treatment by an Analog of Pro-Leu-Gly-NH2 (PLG, MIF-1). Regulatory Peptides. 19:403-406. 1998
-
Design, Synthesis, and Dopamine Receptor Modulating Activity of Diketopiperazine Peptidomimetics of
l -Prolyl-l -leucylglycinamide. Journal of Medicinal Chemistry. 40:3594-3600. 1997 - Modulation of Dopamine Receptor Agonist-Induced Rotational Behavior in 6-OHDA-Lesioned Rats by a Peptidomimetic Analogue of Pro-Leu-Gly-NH2 (PLG). Regulatory Peptides. 18:1209-1215. 1997
- NMDA and dopamine D2L receptor interaction in human neuroblastoma SH-SY5Y cells involves tyrosine kinase and phosphatase. NeuroReport. 7:2937-2940. 1996
- Modulation of dopaminergic neurotransmission in the 6-hydroxydopamine lesioned rotational model by peptidomimetic analogues of l-prolyl-l-leucyl-glycinamide. Brain Research. 737:287-291. 1996
- Interaction of NMDA and Dopamine D2L Receptors in Human Neuroblastoma SH‐SY5Y Cells. Journal of Neurochemistry. 66:2390-2393. 1996
- Modulation of brain catecholamine absorbing proteins by dopaminergic agents. European Journal of Pharmacology. 299:213-220. 1996
- A neurochemical basis for the antipsychotic activity of loxapine: interactions with dopamine D1, D2, D4 and serotonin 5-HT2 receptor subtypes.. Journal of Psychiatry & Neuroscience. 21:29-35. 1996
- Covalent Affinity Labeling of Brain Catecholamine‐Absorbing Proteins Using a High‐Specific‐Activity Substituted Tetrahydronaphthalene. Journal of Neurochemistry. 65:2783-2789. 1995
- Ontogenic development of dopamine D4 receptor in rat brain. Brain Research. 90:180-183. 1995
- Modulation ofN-methyl-d-aspartate (NMDA) antagonist-induced darting behaviour by the peptidomimetic PAMTA. Brain Research. 682:41-49. 1995
- UP-REGULATION OF D-1 DOPAMINE-RECEPTORS IN SK-N-MC CELLS AFTER CHRONIC TREATMENT WITH SCH-23390. Neuroscience Research Communications. 15:157-166. 1994
- Design, Synthesis, X-ray Analysis, and Dopamine Receptor-Modulating Activity of Mimics of the "C5" Hydrogen-Bonded Conformation in the Peptidomimetic 2-Oxo-3(R)-[(2(S)-pyrrolidinylcarbonyl)amino]-1-pyrrolidineacetamide. Journal of Medicinal Chemistry. 37:3677-3683. 1994
- Distribution of cholecystokinin receptors in the bovine brain: A quantitative autoradiographic study. Neuroscience. 62:307-316. 1994
- Striatal G-proteins: Effects of unilateral 6-hydroxydopamine lesions. Neuroscience Letters. 169:195-198. 1994
- Dopamine receptor modulation by a highly rigid spiro bicyclic peptidomimetic of Pro-Leu-Gly-NH2. Journal of Medicinal Chemistry. 36:3481-3483. 1993
- Identification of novel catecholamine absorbing proteins in the central nervous system. Journal of Molecular Neuroscience. 4:141-148. 1993
- Bicyclic thiazolidine lactam peptidomimetics of the dopamine receptor modulating peptide Pro-Leu-Gly-NH2. Journal of Medicinal Chemistry. 36:2356-2361. 1993
- Desensitization of D1 dopamine receptors down-regulates the Gsα subunit of G protein in SK-N-MC neuroblastoma cells. Journal of Molecular Neuroscience. 4:117-123. 1993
- High- and low-affinity states of dopamine D1 receptors in schizophrenia. European Journal of Pharmacology. 233:175-176. 1993
- Synthesis and dopamine receptor modulating activity of lactam conformationally constrained analogs of Pro-Leu-Gly-NH2. Journal of Medicinal Chemistry. 36:256-263. 1993
- Effects of Chronic Treatment of Haloperidol and Clozapine on Levels of G-Protein Subunits in Rat Striatum. Journal of Molecular Neuroscience. 3:197-201. 1992
- Ontogeny of dopamine D2 receptor mRNA in rat brain. European Journal of Pharmacology. 225:143-150. 1992
- Functional Modifications of the Coupling of Solubilized Dopamine D<sub>2</sub> Receptors to Guanine-Nucleotide-Binding Proteins. NeuroSignals. 1:194-207. 1992
- Localization of cholecystokinin binding sites in canine brain using quantitative autoradiography. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 15:291-296. 1991
- The effect of dopamine D1 and D2 receptor agonists on inositol phosphate turnover in rat striatal slices.. IUBMB Life. 22:887-894. 1990
- Effect of haloperidol on expression of dopamine D2 receptor mRNAs in rat brain. Journal of Molecular Neuroscience. 2:155-161. 1990
- Solubilization and reconstitution of dopamine D1 receptor from bovine striatal membranes: Effects of agonist and antagonist pretreatment. Neurochemical Research. 15:647-657. 1990
- Synthesis and biological evaluation of analogs of Pro-Leu-Gly-NH2 modified at the leucyl residue. Journal of Medicinal Chemistry. 33:1828-1832. 1990
- Chemical modification reveals involvement of tyrosine in ligand binding to dopamine D1 and D2 receptors.. IUBMB Life. 21:705-714. 1990
- Identification of α2-adrenergic receptor sites in human retinoblastoma (Y-79) and neuroblastoma (SH-SY5Y) cells. Biochemical and Biophysical Research Communications. 158:921-928. 1989
- Dopamine receptor modulation by conformationally constrained analogs of Pro-Leu-Gly-NH2. Journal of Medicinal Chemistry. 31:1430-1436. 1988
- A STUDY OF QUANTITATIVE STRUCTURE PROPERTY CORRELATIONS (QSPC) APPLYING AN UNUSUAL ADDITIVITY SCHEME. Indian Journal of Chemistry - Section A Inorganic, Physical, Theoretical and Analytical Chemistry. 27:188-191. 1988
- Interaction of l‐Prolyl‐l‐Leucyl Glycinamide with Dopamine D2 Receptor: Evidence for Modulation of Agonist Affinity States in Bovine Striatal Membranes. Journal of Neurochemistry. 50:960-968. 1988
- Sulfated cholecystokinin octapeptide (CCK8) failed to modulate basal or dopamine-stimulated adenylate cyclase activity in the rat striatum. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 12:331-336. 1988
- Synthesis and X-ray diffraction analysis of the tetrazole peptide analogue Pro-LeuΨ[CN4]Gly-NH2. ChemPlusChem. 53:2863-2876. 1988
- 17β Estradiol-induced increase in brain dopamine D-2 receptor: Antagonism by MIF-1. Regulatory Peptides. 8:997-1002. 1987
- Effects of unilateral intracerebroventricular microinjections of cholecystokinin (CCK) on circling behavior of rats. Regulatory Peptides. 8:989-995. 1987
- Down-regulation of haloperidol-induced striatal dopamine receptor supersensitivity by active analogues of L-prolyl-L-leucyl-glycinamide (PLG). Regulatory Peptides. 8:855-861. 1987
- Comparative pharmacological properties and functional coupling of mu and delta opioid receptor sites in human neuroblastoma SH-SY5Y cells.. Molecular Pharmacology. 32:109-118. 1987
- Reconstitution of affinity-purified dopamine D2 receptor binding activities by specific lipids. Biochimica et Biophysica Acta: international journal of biochemistry and biophysics. 900:175-182. 1987
- L-prolyl-L-leucyl-glycinamide analogues--a new class of peptide antihypertensives.. Journal of Hypertension. 4:S106-S108. 1986
- Characterization of High‐Affinity Dopamine D2 Receptors and Modulation of Affinity States by Guanine Nucleotides in Cholate‐Solubilized Bovine Striatal Preparations. Journal of Neurochemistry. 47:1493-1502. 1986
- Dopamine receptor modulation by Pro-Leu-Gly-NH2 analogs possessing cyclic amino acid residues at the C-terminal position. Journal of Medicinal Chemistry. 29:2100-2104. 1986
- Synthesis of Pro-Leu-Gly-NH2 analogs modified at the prolyl residue and evaluation of their effects on the receptor binding activity of the central dopamine receptor agonist, ADTN. Journal of Medicinal Chemistry. 29:2104-2107. 1986
- Purification of bovine striatal dopamine D-2 receptor by affinity chromatography.. Journal of Biological Chemistry. 261:8894-8898. 1986
- Opioid receptors in human neuroblastoma SH-SY5Y cells: Evidence for distinct morphine (μ) and enkephalin (δ) binding sites. Biochemical and Biophysical Research Communications. 137:813-820. 1986
- L-prolyl-L-leucyl-glycinamide (PLG) and its analogs: Clinical implications in extrapyramidal motor disorders and depression. Drugs of the Future. 11:203-207. 1986
- Mesolimbic and striatal dopamine receptor supersensitivity: Prophylactic and reversal effects of L-prolyl-L-leucyl-glycinamide (PLG). Regulatory Peptides. 6:179-183. 1985
- Brain adenylate cyclase activity in the amphetamine sensitized rat. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 9:721-724. 1985
- Factors affecting solubilization of the D1 receptor from bovine caudate nucleus. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 9:749-753. 1985
- REVERSIBLE INHIBITION OF SPECIFIC H-3-SPIROPERIDOL BINDING BY HEAVY-METAL IONS IN RAT STRIATUM. Research Communications in Psychology, Psychiatry and Behavior. 10:221-234. 1985
- The Mechanism of Neuroleptic Withdrawal. Canadian Journal of Psychiatry. 29:508-509. 1984
- CNS Dopamine Receptors: Effect of Prolyl-Leucyl-Glycinamide and Solubilization. Nutrition and Health. 3:175-187. 1984
- Desensitization by Antidepressants of Central Norepinephrine Receptor Systems Coupled to Adenylate Cyclasea. Annals of the New York Academy of Sciences. 430:91-103. 1984
- Characteristics of [3H] propyl beta-carboline-3-carboxylate binding to benzodiazepine receptors in human brain.. Research Communications in Molecular Pathology and Pharmacology. 44:199-213. 1984
- Differential changes in central serotonin and dopamine receptors in spontaneous hypertensive rats. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 8:665-668. 1984
- Characteristics of high affinity binding of [3H]N-acetylserotonin in rat brain. Neuropharmacology. 22:1311-1314. 1983
- Effect of selective monoamine oxidase inhibition by clorgyline and deprenyl on the norepinephrine receptor-coupled adenylate cyclase system in rat cortex. Psychopharmacology. 81:220-223. 1983
- The effects of kindling on GABA-mediated inhibition in the dentate gyrus of the rat. II. Receptor binding. Brain Research. 277:91-98. 1983
- Factors affecting solubilized dopamine-sensitive adenylate cyclase. Biochemical Pharmacology. 32:1237-1241. 1983
- A simple and efficient method for solubilization of the dopamine receptor. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 7:769-772. 1983
- Are the pharmacological effects of L-prolyl-L-leucylglycinamide (PLG) mediated through specific receptor mechanisms?. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 7:739-742. 1983
- Binding studies of L-Prolyl-L-leucyl-glycinamide (PLG), a novel antiparkinsonian agent, in normal human brain. Pharmacological Research Communications. 15:41-51. 1983
- Effects of blinding and pinealectomy on regional brain monoamine concentrations. Journal of Neuroscience Research. 10:53-60. 1983
- Lymphocyte 3H-spiroperidol binding in schizophrenia: preliminary findings. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 7:729-732. 1983
- Modulation of CNS dopamine receptors by peptides. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 7:437-442. 1983
- Pharmacology of L-prolyl-L-leucyl-glycinamide (PLG): a review.. Methods and Findings in Experimental and Clinical Pharmacology. 5:203-233. 1983
- Enhanced [3H]spiroperidol binding in striatum of spontaneously hypertensive rat (SHR). European Journal of Pharmacology. 82:243-244. 1982
- Oxaprotiline: Induction of central noradrenergic subsensitivity by its (+)-enantiomer. Life Sciences. 30:1747-1755. 1982
- A serotonergic component of [3H]N-acetylserotonin binding in mammalian brain. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 6:421-424. 1982
- CNS putative L-prolyl-L-leucyl-glycinamide (PLG) receptors, brain and lymphocyte dopamine receptors. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 6:365-368. 1982
- Neuroleptic Drug-Induced Dopamine Receptor Supersensitivity: Antagonism by L-Prolyl-L-Leucyl-Glycinamide. Science. 214:1261-1262. 1981
- Cyclic AMP response to norepinephrine in the limbic forebrain of male and female rats: effect of desipramine. Biochemical Pharmacology. 30:3126-3128. 1981
- A rapid and simple method for assaying 3H-spiroperidol binding to solubilized dopamine receptors. Pharmacological Research Communications. 13:587-605. 1981
- Effect of L-prolyl-L-leucyl-glycinamide (PLG) on neuroleptic-induced catalepsy and dopamine/neuroleptic receptor bindings. Regulatory Peptides. 2:105-111. 1981
- The noradrenaline receptor coupled adenylate cyclase system in brain. Naunyn-Schmiedeberg's Archives of Pharmacology. 316:218-224. 1981
- Action of mianserin and zimelidine on the norepinephrine receptor coupled adenylate cyclase system in brain: Subsensitivity without reduction in β-adrenergic receptor binding. Neuropharmacology. 19:983-987. 1980
- Supersensitivity in rat caudate nucleus: Effects of 6-hydroxydopamine on the time course of dopamine receptor and cyclic AMP changes. Brain Research. 200:47-57. 1980
- Micellar organization of lipid droplets in human atherosclerotic lesions. Atherosclerosis. 37:139-142. 1980
- A rapid method for measuring 3H-spiroperidol binding to solubilized receptors from bovine striatum. The FASEB Journal. 39:3899. 1980
- Effects of dopaminergic and cholinergic drugs, naloxone and l-prolyl-leucyl-glycinamide on LSD-induced catalepsy. Naunyn-Schmiedeberg's Archives of Pharmacology. 313:45-50. 1980
- Indentification of specific receptor sites for L-prolyl-leucyl-glycinamide (PLG) in mammalian brain. PHARMACOLOGIST. 22:249. 1980
- Localization and characterization of melatonin receptors in CNS cytosol. The FASEB Journal. 39:3902. 1980
- Selective influence of ergot alkaloids on cortical and striatal dopaminergic and sergotonergic receptors.. Advances in biochemical psychopharmacology. 23:83-93. 1980
- Subsensitivity of the norepinephrine receptor-coupled adenylate cyclase system in brain: Effects of Nisoxetine versus fluoxetine. European Journal of Pharmacology. 60:379-382. 1979
- Dopamine antagonist binding increases in two behaviorally distinct striatal denervation syndromes. Brain Research. 170:381-386. 1979
- Effect of D-lysergic acid diethylamide on striatal choline acetyltransferase activity in the rat. Biochemical Pharmacology. 28:2207-2209. 1979
- Melatonin receptors in brain. European Journal of Pharmacology. 55:219-220. 1979
- ANALYSIS OF GESTATION LENGTH IN SIROHI GOATS. Indian Journal of Animal Sciences. 49:967-968. 1979
- Antagonism of morphine-induced catalepsy by L-prolyl-L-leucyl-glycinamide. European Journal of Pharmacology. 53:119-125. 1979
- Stereochemical and dynamic aspects of genetic recombination.. Contributions to microbiology and immunology. 6:222-228. 1979
- The relative role of dopamine and norepinephrine receptor blockade in the action of antipsychotic drugs: Metoclopramide, thiethylperazine, and molindone as pharmacological tools. Psychopharmacology. 64:141-147. 1979
- Effect of substituted benzamide drugs on rat striatal tyrosine hydroxylase. European Journal of Pharmacology. 51:189-190. 1978
- 3H-haloperidol binding: Some theoretical aspects. Life Sciences. 23:471-473. 1978
- 3H-spiroperidol binding and dopamine-stimulated adenylate cyclase: Evidence for multiple classes of receptors in primate brain regions. Life Sciences. 23:629-633. 1978
- Chemical lesion and drug induced supersentivity and subsensitivity of caudate dopamine receptors. Life Sciences. 23:443-446. 1978
- Role of serotonin reuptake inhibition in the development of subsensitivity of the norepinephrine (NE) receptor coupled adenylate cyclase system.. Communications in psychopharmacology. 2:365-369. 1978
- Pre and postsynaptic effects of sulpiride and other substituted benzamides. The FASEB Journal. 36. 1977
- Catecholamine-sensitive adenylate cyclase in frontal cortex of primate brain. Brain Research. 116:437-454. 1976
- Effects of morphine on dopamine-stimulated adenylate cyclase and on cyclic GMP formation in primate brain amygdaloid nucleus. Life Sciences. 19:1129-1137. 1976
- The effect of a bovine hypothalamic factor on mouse brain neurotransmitters. Neuropharmacology. 15:345-348. 1976
- A dopamine-sensitive adenylate cyclase in anterior limbic cortex and mesolimbic region of primate brain. Brain Research. 96:395-399. 1975
- Enhancement of Dopamine-Stimulated Adenylate Cyclase Activity in Rat Caudate after Lesions in Substantia Nigra: Evidence for Denervation Supersensitivity. Proceedings of the National Academy of Sciences of the United States of America. 71:3883-3887. 1974
- Cornu-cutaneum. A case report.. Indian Journal of Ophthalmology. 15:123-124. 1967
- Compound 186 is a Negative Allosteric Modulator of Dopamine D2 Receptors: Implications for Improving Schizophrenia Therapy. The Meducator. 1.
- Relationship between Science and Technology (S&T) and Gross District Domestic Product (GDDP) in select Indian Districts. Asian Biotechnology and Development Review. 21:57-78.
-
preprints